Design, Synthesis, and Evaluation of Alkyl-Quinoxalin-2(1)-One Derivatives as Anti- Molecules, Inhibiting Biofilm Formation in Sch3.

With the increasing antibiotic resistance of bacterial strains, alternative methods for infection control are in high demand. (QS) is the bacterial communication system based on small molecules. QS is enables bacterial biofilm formation and pathogenic development. The interruption of QS has become a target for drug discovery, but remains in the early experimental phase. In this study, we synthesized a set of six compounds based on a scaffold (alkyl-quinoxalin-2(1)-one), new in the anti-QS of Gram-negative bacteria Sch3. By quantifying biofilm formation, we were able to monitor the effect of these compounds from concentrations of 1 to 100 µM. Significant reduction in biofilm formation was achieved by 3-hexylylquinoxalin-2(1)-one (), 3-hexylylquinoxalin-2(1)-one-6-carboxylic acid (), and 3-heptylylquinoxalin-2(1)-one-6-carboxylic acid (), ranging from 11% to 59% inhibition of the biofilm. This pilot study contributes to the development of anti-QS compounds to overcome the clinical challenge of resistant bacteria strains.